3-fluoro-piperidine T-type calcium channel antagonists

Details for Australian Patent Application No. 2006262101 (hide)

Owner Merck & Co., Inc.

Inventors Barrow, James C.; Lindsley, Craig W.; Shipe, William D.; Yang, Zhiqiang

Agent Spruson & Ferguson

Pub. Number AU-A-2006262101

PCT Pub. Number WO2007/002361

Priority 60/693,504 23.06.05 US

Filing date 21 June 2006

Wipo publication date 4 January 2007

International Classifications

C07D 211/38 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

C07D 211/06 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2007/002361 Priority application(s): WO2007/002361

24 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006262110-Aggregating data with complex operations

2006262098-Cardiomyocyte cell populations